(Q40929576)

English

The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy

scientific article published on 5 February 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy (English)

1 reference

Europe PubMed Central

24 September 2017

author name string

Dong Wang

1

1 reference

Europe PubMed Central

24 September 2017

Guangyu An

2

1 reference

Europe PubMed Central

24 September 2017

Shengzhi Xie

3

1 reference

Europe PubMed Central

24 September 2017

Yajuan Yao

4

1 reference

Europe PubMed Central

24 September 2017

Guosheng Feng

5

1 reference

Europe PubMed Central

24 September 2017

publication date

5 February 2016

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

37

1 reference

Europe PubMed Central

24 September 2017

8

1 reference

Europe PubMed Central

24 September 2017

10427-10433

1 reference

Europe PubMed Central

24 September 2017

https://scigraph.springernature.com/pub.10.1007/s13277-016-4916-2

0 references

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Radiation therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Immunotherapeutic strategies for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Myeloid derived suppressor cells in human diseases

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Coordinated regulation of myeloid cells by tumours

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Myeloid derived suppressor cells: Targets for therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Strategies to improve radiotherapy with targeted drugs

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

New paradigms and future challenges in radiation oncology: an update of biological targets and technology

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4916-2

21 January 2018

Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26846107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26846107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26846107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alcoholic liver disease - Hepatocellular carcinoma transformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26846107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

1 reference

https://pubmed.ncbi.nlm.nih.gov/26846107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26846107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-016-4916-2

1 reference

Europe PubMed Central

24 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40929576&oldid=1910847541"